In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 4, 2006, Pages 681-689

  Sperling, Claudia ^a   Houska, Milan ^b   Brynda, Eduard ^b   Streller, Uwe ^a   Werner, Carsten ^a,c  

^a LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^b INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Albumin; Coagulation; Complement; Hemocompatibility; Heparin; Layer by layer coating; Platelet adhesion; Polyethersulfone

Indexed keywords

BIOACTIVITY; BIOLOGICAL MEMBRANES; BLOOD; COATINGS; MULTILAYERS; PURIFICATION;

HEMOCOMPATIBILITY; LAYER-BY-LAYER COATING; PLATELET ADHESION; POLYETHERSULFONE;

PROTEINS;

ALBUMIN; HEPARIN; POLYETHERSULFONE; ALBUMINOID; BIOMATERIAL; POLYMER; SULFONE;

ARTICLE; BLOOD CLOTTING; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEMOFILTRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PURIFICATION; SHEAR FLOW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; CELL ADHESION; CHEMISTRY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE;

ALBUMINS; BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; BLOOD PLATELETS; CELL ADHESION; COMPLEMENT ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PLATELET ACTIVATION; POLYMERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONES;

EID: 33745557818     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30519     Document Type: Article

References (48)

1. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: Roles of coagulation factors, complement, platelets and leucocytes. Biomaterials 2004;25:5681-5703.
2. Wendel HP, Ziemer G. Coating techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-350.
3. Samtleben W, Dengler C, Reinhardt B, Nothdurft A, Lemke HD. Comparison of the new Polyethersulfone high-flux membrane DIAPES HF800 with conventional high-flux membranes during on/line haemodiafiltration. Nephrol Dial Transplant 2003;18:2382-2386.
4. David S, Gerra D, De Nitti C, Bussolati B, Teatini U, Longhema GR, Guastoni C, Bellotti N, Combarbnous F, Tetta C. Hemodiafiltration and high-flux hemodialysis with polyethersulfone membranes. Contrib Nephrol 2003;138:43-54.
5. von Segesser LK. Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass. J Thorac Cardiovasc Surg FEB 2001;121:200-201.
6. de Vroege R, van Oeveren W, van Klarenbosch J, Stooker W, Huybregts MA, Hack CE, van Barneveld L, Eijsman L, Wildevuur CR. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. Anesth Analg 2004;98:1586-1594.
7. Jensen E, Andreasson S, Bengtsson A, Berggren H, Ekroth R, Larsson LE, Ouchterlony J. Changes in hemostasis during pediatric heart surgery: Impact of a biocompatible heparin-coated perfusion system. Ann Thorac Surg 2004;77(3):962-967.
8. Lin PH, Bush RL, Yao Q, Lumsden AB, Chen C. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. J Surg Res 2004;118:45-52.
9. Gupta V, Aravamuthan BR, Baskerville S, Smith SK, Gupta V, Lauer MA, Fischell TA. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry. J Invasive Cardiol 2004;16(6):304-310.
10. Lee KB, Kim B, Lee YH, Yoon SJ, Kang WH, Huh W, Kim DJ, Oh HY, Kim YG. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding. Nephron Clin Pract 2004;97(1):5-10.
11. Larm O, Larsson R, Olsson P. Surface immobilized heparin. In: Lane DA, Lindahl U, editors. Heparin, chemical and biological properties, clinical applications London: Edward Arnold; 1989. p 597-608.
12. Andersson J, Sanchez J, Ekhdal KN, Elgue G, Nilsson B, Larsson R. Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. J Biomed Mater Res 2003;67A:459-466.
13. Czech Pat. 270919. (1990) (Appl. Dec. 30, 1986) Academy of Sciences of the Czech Republic, in vs.: Brynda E, Houska M, Vacík J, Kálal J, Novikova SP, Ilina B, Selezneva MN, Dobrova NB, MPT A 61 L 33/00.
14. Brynda E, Houska M. Multiple alternating molecular layers of albumin and heparin on solid surfaces. J Colloid Interface Sci 1996;183:18-25.
15. Houska M, Brynda E. Interactions of proteins with polyelectrolytes at solid/liquid interfaces: Sequential adsorption of albumin and heparin. J Colloid Interface Sci 1997;188:243-270.
16. Brynda E, Houska M. Preparation of organized protein multilayers. Macromol Rapid Commun 1998;19:173-176.
17. Brynda E, Houska M, Jirouskova M, Dyr JE. Albumin and heparin multilayer coatings for blood/contacting medical devices. J Biomed Mater Res 2000;51:249-257.
18. Brynda E, Houska M. Ordered multilayer assemblies: Albumin/heparin for biocompatible coatings and monoclonal antibodies for optical immunosensors. In: Lvov Y, Möhwald H, editors. Protein architecture: Interfacing molecular assemblies and immobilization technology. New York: Marcel Dekker; 2000. p 251-286.
19. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G, Wadenvik H. The effect of albumin priming solution on platelet activation during experimental long-term perfusion. Perfusion 1998;13:187-191.
20. Borgdorf P, van den Berg RH, Vis MA, van den Bos GC, Tangelder J. Pump-induced platelet aggregation in albumin-coated extracorporeal systems. J Thorac Cardiovasc Surg 1999; 118:946-952.
21. Kottke-Merchant K, Anderson JM, Umemura Y, Merchant RE. Effect of albumin coating on the blood compatibility of Dacron arterial prosthesis. Biomaterials 1989;10:147-155.
22. Amiji M. Park H, Park K. Study of prevention of surface induced platelet activation by albumin coating. J Biomater Sci Polym Ed 1992;3:375-388.
23. Solov'ev AYu, Brynda E, Houska M, Bleha M, Shataeva LK. Deposition of a multilayered protein coating onto poly(ethylene terephtalate). Polym Sci Ser B 2003;45:267-271.
24. Brynda E, Homola J, Houska M, Pfeifer P, Skvor J. Antibody networks for surface plasmon resonance immunosensors. Sensors Actuators 1999;B54:132-144.
25. 2-microglobulin by grating coupler immunosensor with three-dimensional antibody networks. Biosens Bioelectron 1999;14:363-367.
26. Brynda E, Houska M, Wikerstal A, Brandenburg A. Optical biosensors for real-time measurement of analytes in blood. Biosens Bioelectron 2002;17:665-669.
27. Brynda E, Houska M, Pientka Z, Pacherník J, Dvoøák P. Material surface modification with organized multilayer assemblies of biological macromolecules. Eur Cells Mater J Suppl 2004;1:20.
28. Bertrand P, Jonas A, Laschewsky A, Legras R. Ultrathin polymer coatings by complexation of polyelectrolytes at interfaces: Suitable materials, structure and properties. Macromol Rapid Commun 2000;21:319-348.
29. Lvov Y, Möhwald H, editors. Protein architecture: Interfacing molecular assemblies and immobilization technology. New York: Marcel Dekker; 2000.
30. Decher G, Schlenoff JB, editors. Multilayer thin films - Sequential assembly of nanocomposite materials. Weinheim: Wiley-VCH; 2002.
31. Streller U, Sperling C, Hübner J, Hanke R, Werner C. Design and evaluation of novel blood incubation systems for in vitro hemocompatibility assessment of planar solid surfaces. J Biomed Mater Res Part B: Appl Biomater 2003;66:379-390.
32. Gouzy MF, Sperling C, Salchert K, Pompe T, Streller U, Uhlmann P, Rauwolf C, Simon F, Böhme F, Voit B, Werner C. In vitro blood compatibility of polymeric biomaterials through covalent immobilization of an amidine derivative. Biomaterials 2004;25(17):3493-3501.
33. Sperling C, Salchert K, Streller U, Werner C. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro. Biomaterials 2004; 25:5101-5113.
34. von Segesser L, Turina M. Cardioplumonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1989;98:386-396.
35. Nakajima T, Kawazoe K, Ishibashi K, Kubota Y, Sasaki T, Izumoto H, Nikatori T. Reduction of heparin dose is not beneficial to platelet function. Ann Thorac Surg 2000;70:196-190.
36. Barman S, Danby A, Cowan D, Ashraf S, Martin PG. Low Heparinization with heparin-bonded bypass circuits: Is it a safe strategy? Ann Thorac Surg 1997;63:663-668.
37. Johnell M, Elgue G, Larsson R, Larsson A, Thelin S, Siegbahn A. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg 2002;124:321-332.
38. Houska M, Brynda E, Bohata K. The effect of polyelectrolyte chain length on layer-by-layer protein/polyelectrolyte assembly - An experimental study. J Colloid Interface Sci 2004;273: 140-147.
39. Bos GW, Scharenborg NM, Poot AA, Engbers GH, Beugeling T, van Aken WC, Feijen J. Blood compatibility of surfaces with immobilized albumin-heparin conjugate and effect of endothelial cell seeding on platelet adhesion. J Biomed Mater Res 1999;47:279-291.
40. Yap CL, Anderson KE, Hughan SC, Dopheide SM, Salem HH, Jackson SP. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/ V/IX and integrin aIIbβ3. Blood 2002;99:151-158.
41. Videm V. Endpoint-attached heparin blocks neutrophil sticking and spreading. Biomaterials 2004;25:43-51.
42. Edens RE, Linhardt RJ, Weiler JM. Heparin is not just an anticoagulant anymore: Six and one-half decades of studies on the ability of heparin to regulate complement activity. Compl Today, Compl Profiles 1993;1:96-120.
43. Lappegard KT, Fung M, Bergseth G, Riesenfeld J, Lambris JD, Videm V, Mollnes TE. Effect of complement inhibition and heparin coating on artificial surface-induced leucocyte and platelet activation. Ann Thorac Surg 2004;77:932-941.
44. Andersson J, Larsson R, Richter R, Ekdahl KN, Nilsson B. Binding of a model regulator of complement activation (RCA) to a biomaterial surface: Surface-bound factor H inhibits complement activation. Biomaterials 2001;22:2465-2443.
45. Kopp R, Mottaghy K, Kirschfink M. Mechanism of complement activation during extracorporeal blood-biomaterial interaction: Effects of heparin coated and uncoated surfaces. ASAIO J 2002;48:598-605.
46. Cheung AK, Parker CJ, Janatova J, Brynda E. Modulation of complement activation on hemodialysis membranes by immobilized heparin. J Am Soc Nephrol 1992;2:1328-1337.
47. Velthuis HT, Jansen PGM, Hack CE, Eijsman L, Wildevuur CRH. Specific complement inhibition with heparin-coated extracorporeal circuits. Ann Thorac Surg 1996;61:1153-1157.
48. Boackle RJ, Caugham GB, Vesely J, Medgyesli G, Fudenberg HH. Potentiation of factor H by heparin: A rate-limiting mechanism for inhibition of the alternative complement pathway. Mol Immunol 1983;20:1157-1164.